Sign Up Today and Learn More About Myome Stock
Invest in or calculate the value of your shares in Myome or other pre-IPO companies through EquityZen's platform.
Myome Stock (MYOM)
Myome helps identify genes that cause disease and act based on leading science.
About Myome Stock
Founded
2017
Headquarters
Palo Alto, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Myome Press Mentions
Stay in the know about the latest news on Myome
Playing the Long Game: At ACMG, Firms Tout Long-Read Offerings for Rare Disease Testing
genomeweb • Mar 21, 2026
MyOme Demonstrates Clinical Validity of Integrated Polygenic and Clinical Risk Prediction for Coronary Artery Disease
prnewswire • Mar 20, 2026
Natera Announces Commercial Launch of Zenith™ Genomics for Rare Disease Diagnosis
biospace • Mar 12, 2026
MyOme Debuts Zenith™ Portfolio with Natera and Launches Long-Read Methylation Analysis at ACMG 2026
prnewswire • Mar 12, 2026
Broad's campus will be open Monday for essential onsite activities only
einpresswire • Feb 23, 2026
Myome Management
Leadership team at Myome
CEO
Premal S. Shah
Lead Frontend Engineer
Mansi Saini
Join now and verify your accreditation status to gain access to:
- Myome Current Valuation
- Myome Stock Price
- Myome Management
- Available deals in Myome and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Myome Cap Table and Funding History by Share Class and Liquidity Preferences
- Myome Revenue and Financials
- Myome Highlights
- Myome Business Model
- Myome Risk Factors
- Myome Research Report from SACRA Research
Trading Myome Stock
How to invest in Myome stock?
Accredited investors can buy pre-IPO stock in companies like Myome through EquityZen funds. These investments are made available by existing Myome shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Myome stock?
Shareholders can sell their Myome stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
